These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 22113851)

  • 1. Shedding light on Alzheimer's β-amyloid aggregation with chemical tools.
    Kapurniotu A
    Chembiochem; 2012 Jan; 13(1):27-9. PubMed ID: 22113851
    [No Abstract]   [Full Text] [Related]  

  • 2. Design and evaluation of a 6-mer amyloid-beta protein derived phage display library for molecular targeting of amyloid plaques in Alzheimer's disease: Comparison with two cyclic heptapeptides derived from a randomized phage display library.
    Larbanoix L; Burtea C; Ansciaux E; Laurent S; Mahieu I; Vander Elst L; Muller RN
    Peptides; 2011 Jun; 32(6):1232-43. PubMed ID: 21575663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Beta/A4-type amyloid protein in Alzheimer's disease and cerebral amyloid angiopathies].
    Hirai S; Okamoto K
    Nihon Naika Gakkai Zasshi; 1993 Sep; 82(9):1424-9. PubMed ID: 8245639
    [No Abstract]   [Full Text] [Related]  

  • 4. The amyloid beta peptide: a chemist's perspective. Role in Alzheimer's and fibrillization.
    Hamley IW
    Chem Rev; 2012 Oct; 112(10):5147-92. PubMed ID: 22813427
    [No Abstract]   [Full Text] [Related]  

  • 5. Low-n oligomers as therapeutic targets of Alzheimer's disease.
    Ono K; Yamada M
    J Neurochem; 2011 Apr; 117(1):19-28. PubMed ID: 21244429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential inplications of endogenous aldehydes in beta-amyloid misfolding, oligomerization and fibrillogenesis.
    Chen K; Maley J; Yu PH
    J Neurochem; 2006 Dec; 99(5):1413-24. PubMed ID: 17074066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of retro-inverso peptides as anti-aggregation drugs for β-amyloid in Alzheimer's disease.
    Matharu B; El-Agnaf O; Razvi A; Austen BM
    Peptides; 2010 Oct; 31(10):1866-72. PubMed ID: 20633587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of tachykinin neuropeptides on amyloid β aggregation.
    Flashner E; Raviv U; Friedler A
    Biochem Biophys Res Commun; 2011 Apr; 407(1):13-7. PubMed ID: 21352807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amyloid-β: the seeds of darkness.
    Fodero-Tavoletti MT; Villemagne VL; Rowe CC; Masters CL; Barnham KJ; Cappai R
    Int J Biochem Cell Biol; 2011 Sep; 43(9):1247-51. PubMed ID: 21601003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alzheimer's disease.
    Querfurth HW; LaFerla FM
    N Engl J Med; 2010 Jan; 362(4):329-44. PubMed ID: 20107219
    [No Abstract]   [Full Text] [Related]  

  • 11. Research highlights possible Alzheimer's disease trigger: scientists gain new understanding of the trigger mechanisms in the advent and development of Alzheimer's disease.
    Marum L
    Future Med Chem; 2012 Jun; 4(10):1215. PubMed ID: 22800366
    [No Abstract]   [Full Text] [Related]  

  • 12. Astrocytes contain amyloid-β annular protofibrils in Alzheimer's disease brains.
    Lasagna-Reeves CA; Kayed R
    FEBS Lett; 2011 Oct; 585(19):3052-7. PubMed ID: 21872592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aluminum, copper, iron and zinc differentially alter amyloid-Aβ(1-42) aggregation and toxicity.
    Bolognin S; Messori L; Drago D; Gabbiani C; Cendron L; Zatta P
    Int J Biochem Cell Biol; 2011 Jun; 43(6):877-85. PubMed ID: 21376832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure inducing ionic liquids-enhancement of alpha helicity in the Abeta(1-40) peptide from Alzheimer's disease.
    Debeljuh N; Barrow CJ; Henderson L; Byrne N
    Chem Commun (Camb); 2011 Jun; 47(22):6371-3. PubMed ID: 21547327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacterial inclusion bodies of Alzheimer's disease β-amyloid peptides can be employed to study native-like aggregation intermediate states.
    Dasari M; Espargaro A; Sabate R; Lopez del Amo JM; Fink U; Grelle G; Bieschke J; Ventura S; Reif B
    Chembiochem; 2011 Feb; 12(3):407-23. PubMed ID: 21290543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do amyloid β-associated factors co-deposit with Aβ in mouse models for Alzheimer's disease?
    Timmer NM; Kuiperij HB; de Waal RM; Verbeek MM
    J Alzheimers Dis; 2010; 22(2):345-55. PubMed ID: 20847441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surface-modified protein microspheres capture amyloid-β and inhibit its aggregation and toxicity.
    Richman M; Wilk S; Skirtenko N; Perelman A; Rahimipour S
    Chemistry; 2011 Sep; 17(40):11171-7. PubMed ID: 21887833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High ability of apolipoprotein E4 to stabilize amyloid-β peptide oligomers, the pathological entities responsible for Alzheimer's disease.
    Cerf E; Gustot A; Goormaghtigh E; Ruysschaert JM; Raussens V
    FASEB J; 2011 May; 25(5):1585-95. PubMed ID: 21266538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amyloid-beta induces disulfide bonding and aggregation of GAPDH in Alzheimer's disease.
    Cumming RC; Schubert D
    FASEB J; 2005 Dec; 19(14):2060-2. PubMed ID: 16186172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zinc-induced dimerization of the amyloid-β metal-binding domain 1-16 is mediated by residues 11-14.
    Kozin SA; Mezentsev YV; Kulikova AA; Indeykina MI; Golovin AV; Ivanov AS; Tsvetkov PO; Makarov AA
    Mol Biosyst; 2011 Apr; 7(4):1053-5. PubMed ID: 21350790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.